Sleep Loss and Cytokines Levels in an Experimental Model of Psoriasis

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Hirotsu, Camila ^a   Rydlewski, Mariana ^a   Araújo, Mariana Silva ^a   Tufik, Sergio ^a   Andersen, Monica Levy ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; KALLIKREIN 5; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; STRESS HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE EXACERBATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EPIDERMIS; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PREDICTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PSORIASIS; RISK FACTOR; SLEEP DEPRIVATION;

ANIMALS; BODY WEIGHT; CORTICOSTERONE; CYTOKINES; DISEASE MODELS, ANIMAL; KALLIKREINS; MALE; MICE; MICE, INBRED BALB C; PSORIASIS; SKIN; SLEEP DEPRIVATION; STRESS, PSYCHOLOGICAL;

ANIMALIA; MUS;

EID: 84870585763     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051183     Document Type: Article

References (75)

1. Schafer T, (2006) Epidemiology of psoriasis. Review and the German perspective. Dermatology 212: 327-337.
2. Gibson TL, Cohen P, (1999) Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases. Growth Horm IGF Res 9: 241-253.
3. Rogalski C, Meyer-Hoffert U, Proksch E, Wiedow O, (2002) Human leukocyte elastase induces keratinocyte proliferation in vitro and in vivo. J Invest Dermatol 118: 49-54.
4. Glinski W, Kuligowski M, Pierozynska-Dubowska M, Glinska-Ferenz M, Jablonska S, (1991) Ultrastructural changes of the skin induced by human leukocyte elastase and cathepsin G. Acta Derm Venereol. 71: 277-282.
5. Kawada A, Hara K, Kominami E, Hiruma M, Noguchi H, et al. (1997) Processing of cathepsins L, B and D in psoriatic epidermis. Arch Dermatol Res 289: 87-93.
6. Barker JN, (2001) Genetic aspects of psoriasis. Clin Exp Dermatol 26: 321-325.
7. Skov L, Baadsgaard O, (2000) Bacterial superantigens and inflammatory skin diseases. Clin Exp Dermatol 25: 57-61.
8. Gupta MA, Gupta AK, Kirkby S, Schork NJ, Gorr SK, et al. (1989) A psychocutaneous profile of psoriasis patients who are stress reactors. A study of 127 patients. Gen Hosp Psychiatry 11: 166-173.
9. Asadullah K, Docke WD, Volk HD, Sterry W, (1999) The pathophysiological role of cytokines in psoriasis. Drugs Today (Barc) 35: 913-924.
10. Canete JD, Martinez SE, Farres J, Sanmarti R, Blay M, et al. (2000) Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis 59: 263-268.
11. Roussaki-Schulze AV, Kouskoukis C, Petinaki E, Klimi E, Zafiriou E, et al. (2005) Evaluation of cytokine serum levels in patients with plaque-type psoriasis. Int J Clin Pharmacol Res 25: 169-173.
12. Asadullah K, Friedrich M, Hanneken S, Rohrbach C, Audring H, et al. (2001) Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings. J Invest Dermatol 116: 721-727.
13. Ekholm E, Egelrud T, (1999) Stratum corneum chymotryptic enzyme in psoriasis. Arch Dermatol Res 291: 195-200.
14. Ovaere P, Lippens S, Vandenabeele P, Declercq W, (2009) The emerging roles of serine protease cascades in the epidermis. Trends Biochem Sci 34: 453-463.
15. de Korte J, Sprangers MA, Mombers FM, Bos JD, (2004) Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc 9: 140-147.
16. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, et al. (2001) The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 137: 280-284.
17. Gowda S, Goldblum OM, McCall WV, Feldman SR, (2010) Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol 63: 114-123.
18. Ruiz FS, Andersen ML, Martins RC, Zager A, Lopes JD, et al. (2012) Immune alterations after selective rapid eye movement or total sleep deprivation in healthy male volunteers. Innate Immun 18: 44-54.
19. van Leeuwen WM, Lehto M, Karisola P, Lindholm H, Luukkonen R, et al. (2009) Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. PLoS One 4: e4589.
20. Moldofsky H, Lue FA, Davidson JR, Gorczynski R, (1989) Effects of sleep deprivation on human immune functions. FASEB J 3: 1972-1977.
21. Zager A, Ruiz FS, Tufik S, Andersen ML, (2012) Immune outcomes of paradoxical sleep deprivation on cellular distribution in naive and lipopolysaccharide-stimulated mice. Neuroimmunomodulation 19: 79-87.
22. Benedict C, Dimitrov S, Marshall L, Born J, (2007) Sleep enhances serum interleukin-7 concentrations in humans. Brain Behav Immun 21: 1058-1062.
23. Reis ES, Lange T, Kohl G, Herrmann A, Tschulakow AV, et al. (2011) Sleep and circadian rhythm regulate circulating complement factors and immunoregulatory properties of C5a. Brain Behav Immun 25: 1416-1426.
24. Dimitrov S, Lange T, Tieken S, Fehm HL, Born J, (2004) Sleep associated regulation of T helper 1/T helper 2 cytokine balance in humans. Brain Behav Immun 18: 341-348.
25. Moynihan J, Rieder E, Tausk F, (2010) Psychoneuroimmunology: the example of psoriasis. G Ital Dermatol Venereol 145: 221-228.
26. Gates AH, Karasek M, (1965) Hereditary Absence of Sebaceous Glands in the Mouse. Science 148: 1471-1473.
27. Rogozinski R, Derewenda A, Torzecka W, Bortkiewicz A, Patewicz K, et al. (1986) [Hemoglobin A1c in pregnant women with diabetes mellitus]. Ginekol Pol 57: 30-34.
28. Sundberg JP, Beamer WG, Shultz LD, Dunstan RW, (1990) Inherited mouse mutations as models of human adnexal, cornification, and papulosquamous dermatoses. J Invest Dermatol 95: 62S-63S.
29. Wiedow O, Wiese F, Christophers E, (1995) Lesional elastase activity in psoriasis. Diagnostic and prognostic significance. Arch Dermatol Res 287: 632-635.
30. Groves RW, Mizutani H, Kieffer JD, Kupper TS, (1995) Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. Proc Natl Acad Sci U S A 92: 11874-11878.
31. Turksen K, Kupper T, Degenstein L, Williams I, Fuchs E, (1992) Interleukin 6: insights to its function in skin by overexpression in transgenic mice. Proc Natl Acad Sci U S A 89: 5068-5072.
32. Carroll JM, Crompton T, Seery JP, Watt FM, (1997) Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss. J Invest Dermatol 108: 412-422.
33. Vassar R, Fuchs E, (1991) Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev 5: 714-727.
34. Blessing M, Schirmacher P, Kaiser S, (1996) Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol 135: 227-239.
35. Nickoloff BJ, (1991) The cytokine network in psoriasis. Arch Dermatol 127: 871-884.
36. Zager A, Andersen ML, Lima MM, Reksidler AB, Machado RB, et al. (2009) Modulation of sickness behavior by sleep: the role of neurochemical and neuroinflammatory pathways in mice. Eur Neuropsychopharmacol 19: 589-602.
37. Silva RH, Abilio VC, Takatsu AL, Kameda SR, Grassl C, et al. (2004) Role of hippocampal oxidative stress in memory deficits induced by sleep deprivation in mice. Neuropharmacology 46: 895-903.
38. Kitka T, Katai Z, Pap D, Molnar E, Adori C, et al. (2009) Small platform sleep deprivation selectively increases the average duration of rapid eye movement sleep episodes during sleep rebound. Behav Brain Res 205: 482-487.
39. Mussi A, Bonifati C, Carducci M, Viola M, Tomaselli R, et al. (1994) IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids. J Biol Regul Homeost Agents 8: 117-120.
40. Griffiths CE, Richards HL, (2001) Psychological influences in psoriasis. Clin Exp Dermatol 26: 338-342.
41. Langley RG, Krueger GG, Griffiths CE (2005) Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 64 Suppl 2: ii18-23; discussion ii24-15.
42. Araujo P, Mazaro-Costa R, Tufik S, Andersen ML, (2011) Impact of sex on hyperalgesia induced by sleep loss. Horm Behav 59: 174-179.
43. Andersen ML, Bignotto M, Machado RB, Tufik S, (2004) Different stress modalities result in distinct steroid hormone responses by male rats. Braz J Med Biol Res 37: 791-797.
44. Zager A, Andersen ML, Ruiz FS, Antunes IB, Tufik S, (2007) Effects of acute and chronic sleep loss on immune modulation of rats. Am J Physiol Regul Integr Comp Physiol 293: R504-509.
45. Park E, Chan O, Li Q, Kiraly M, Matthews SG, et al. (2005) Changes in basal hypothalamo-pituitary-adrenal activity during exercise training are centrally mediated. Am J Physiol Regul Integr Comp Physiol 289: R1360-1371.
46. Morizane S, Yamasaki K, Kajita A, Ikeda K, Zhan M, et al. (2012) TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis. J Allergy Clin Immunol 130: 259-261 e251.
47. Kono M, Nagata H, Umemura S, Kawana S, Osamura RY, (2001) In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. FASEB J 15: 2297-2299.
48. Richards HL, Ray DW, Kirby B, Mason D, Plant D, et al. (2005) Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol 153: 1114-1120.
49. Elkayam O, Yaron I, Shirazi I, Yaron M, Caspi D, (2000) Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 19: 101-105.
50. Ozawa M, Aiba S, (2004) Immunopathogenesis of psoriasis. Curr Drug Targets Inflamm Allergy 3: 137-144.
51. Seifert M, Sterry W, Effenberger E, Rexin A, Friedrich M, et al. (2000) The antipsoriatic activity of IL-10 is rather caused by effects on peripheral blood cells than by a direct effect on human keratinocytes. Arch Dermatol Res 292: 164-172.
52. Takahashi H, Tsuji H, Hashimoto Y, Ishida-Yamamoto A, Iizuka H, (2010) Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 35: 645-649.
53. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, et al. (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci U S A 86: 6367-6371.
54. Neuner P, Urbanski A, Trautinger F, Moller A, Kirnbauer R, et al. (1991) Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol 97: 27-33.
55. Asadullah K, Sabat R, Friedrich M, Volk HD, Sterry W, (2004) Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy 3: 185-192.
56. Asadullah K, Eskdale J, Wiese A, Gallagher G, Friedrich M, et al. (2001) Interleukin-10 promoter polymorphism in psoriasis. J Invest Dermatol 116: 975-978.
57. Asadullah K, Docke WD, Ebeling M, Friedrich M, Belbe G, et al. (1999) Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial. Arch Dermatol 135: 187-192.
58. Baran W, Szepietowski JC, Mazur G, Baran E, (2008) IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris. Acta Derm Venereol 88: 113-116.
59. Pandey AK, Kar SK, (2011) REM sleep deprivation of rats induces acute phase response in liver. Biochem Biophys Res Commun 410: 242-246.
60. Yehuda S, Sredni B, Carasso RL, Kenigsbuch-Sredni D, (2009) REM sleep deprivation in rats results in inflammation and interleukin-17 elevation. J Interferon Cytokine Res 29: 393-398.
61. Schon MP, Detmar M, Parker CM, (1997) Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat Med 3: 183-188.
62. Morrissey PJ, Charrier K, Braddy S, Liggitt D, Watson JD, (1993) CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 178: 237-244.
63. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL, (1993) Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 5: 1461-1471.
64. Arjona A, Sarkar DK, (2005) Circadian oscillations of clock genes, cytolytic factors, and cytokines in rat NK cells. J Immunol 174: 7618-7624.
65. Arjona A, Sarkar DK, (2006) The circadian gene mPer2 regulates the daily rhythm of IFN-gamma. J Interferon Cytokine Res 26: 645-649.
66. Esquifino AI, Selgas L, Arce A, Maggiore VD, Cardinali DP, (1996) Twenty-four-hour rhythms in immune responses in rat submaxillary lymph nodes and spleen: effect of cyclosporine. Brain Behav Immun 10: 92-102.
67. Scheff JD, Calvano SE, Lowry SF, Androulakis IP, (2010) Modeling the influence of circadian rhythms on the acute inflammatory response. J Theor Biol 264: 1068-1076.
68. Perry MG, Kirwan JR, Jessop DS, Hunt LP, (2009) Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 68: 63-68.
69. Halberg F, Johnson EA, Brown BW, Bittner JJ, (1960) Susceptibility rhythm to E. coli endotoxin and bioassay. Proc Soc Exp Biol Med 103: 142-144.
70. Castanon-Cervantes O, Wu M, Ehlen JC, Paul K, Gamble KL, et al. (2010) Dysregulation of inflammatory responses by chronic circadian disruption. J Immunol 185: 5796-5805.
71. Dimitrov S, Lange T, Nohroudi K, Born J, (2007) Number and function of circulating human antigen presenting cells regulated by sleep. Sleep 30: 401-411.
72. Silver AC, Arjona A, Walker WE, Fikrig E, (2012) The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity 36: 251-261.
73. Besedovsky L, Lange T, Born J, (2012) Sleep and immune function. Pflugers Arch 463: 121-137.
74. Mozzanica N, Tadini G, Radaelli A, Negri M, Pigatto P, et al. (1988) Plasma melatonin levels in psoriasis. Acta Derm Venereol 68: 312-316.
75. Radaelli A, Carandente F, Tadini G, Ronchi M, Zoccoli A, et al. (1982) Circadian temporal structure in psoriasis. Chronobiologia 9: 203-209.